We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Analytical Cannabis Logo
Home > About Us > Alexander Beadle

Alexander Beadle

Science Writer

Alexander Beadle has been working as a freelance science writer since 2017 and has covered the cannabis industry for Analytical Cannabis since 2018. He has also written for our sister publication, Technology Networks, and the cannabis industry consultant firm Prohibition Partners, among others. Alexander holds a Master's in Materials Chemistry from the University of St. Andrews, where he won a Chemistry Purdie scholarship, and conducted research into zeolite crystal growth mechanisms and the action of single-molecule transistors.

Latest content from Alexander Beadle

Analytical Cannabis Digest - September 2022

Download this FREE monthly resource to stay up to date with the latest developments in the cannabis industry.


Pharmaceutical Companies Lose Billions When US States Legalize Cannabis, Study Finds

Just one US state legalizing cannabis can cost the pharmaceutical sector nearly $10 billion, according to a new, first-of-its-kind study from researchers at California Polytechnic State University and the University of New Mexico.


Cannabis Use Jumps By 20% in Legal States, Study of Identical Twins Finds

Researchers used survey data from more than 3,400 adult twins – 111 of which were identical – to study recent trends in cannabis use and the factors affecting it.


Cannabis Improves Sperm Quality in Rats, Study Finds

Further research into cannabis leaf extracts may one day lead to the discovery of new drugs for treating infertility, the researchers say.


Technological Advances in Cannabis Testing

Welcome to our latest eBook, Technological Advances in Cannabis Testing, a collection of features on some of the most exciting developments in marijuana testing, penned by some of the brilliant people making them happen.


Psychedelic Drugs Lessen Fear of Dying, Study Suggests

A psychedelic drug experience may alter people’s perspectives on death and dying in a similar way to those who have survived a near-death experience, a new study has found.


Psilocybin and Ketamine Are Safer Than Xanax, Say US Psychiatrists

Most American psychiatrists view psilocybin and ketamine as safer drugs than alprazolam (Xanax), methamphetamine, or alcohol, according to a new survey.


Psilocybin-Assisted Therapy Can Treat Alcohol Use Disorder, Trial Finds

The first controlled trial of psilocybin for alcohol use disorder (AUD) reports that psilocybin-assisted psychotherapy significantly reduces the occurrence of heavy drinking days in people with AUD.


Most Cannabis Plants Contain Mitoviruses, Study Finds

In a recently published white paper, Segra scientists report that 77% of the cannabis cultivars they have screened so far tested positive for the cannabis mitovirus, CaMV1. But far from being a point of concern, the scientists suggest that this mitovirus may even be somehow beneficial to the cannabis plant.


Curaleaf Pulls Thousands of Products Off Shelves After THC Labeling Switch

The multi-state operator has pulled tens of thousands of its products off of New York State shelves after the company switched to an unauthorized way of labeling product potency.